Multi-ancestry meta-analysis and fine-mapping in Alzheimer's disease.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 20 10 2022
accepted: 31 03 2023
revised: 27 03 2023
medline: 1 11 2023
pubmed: 18 5 2023
entrez: 17 5 2023
Statut: ppublish

Résumé

Genome-wide association studies (GWAS) of Alzheimer's disease are predominantly carried out in European ancestry individuals despite the known variation in genetic architecture and disease prevalence across global populations. We leveraged published GWAS summary statistics from European, East Asian, and African American populations, and an additional GWAS from a Caribbean Hispanic population using previously reported genotype data to perform the largest multi-ancestry GWAS meta-analysis of Alzheimer's disease and related dementias to date. This method allowed us to identify two independent novel disease-associated loci on chromosome 3. We also leveraged diverse haplotype structures to fine-map nine loci with a posterior probability >0.8 and globally assessed the heterogeneity of known risk factors across populations. Additionally, we compared the generalizability of multi-ancestry- and single-ancestry-derived polygenic risk scores in a three-way admixed Colombian population. Our findings highlight the importance of multi-ancestry representation in uncovering and understanding putative factors that contribute to risk of Alzheimer's disease and related dementias.

Identifiants

pubmed: 37198259
doi: 10.1038/s41380-023-02089-w
pii: 10.1038/s41380-023-02089-w
pmc: PMC10615750
doi:

Types de publication

Meta-Analysis Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3121-3132

Subventions

Organisme : NIA NIH HHS
ID : R01 AG062588
Pays : United States
Organisme : NINDS NIH HHS
ID : U54 NS123985
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062422
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA NS003154
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 AG000949
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG057234
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Tanzi RE, Bertram L. New frontiers in Alzheimer’s disease genetics. Neuron. 2001;32:181–4.
pubmed: 11683989 doi: 10.1016/S0896-6273(01)00476-7
Holland D, Frei O, Desikan R, Fan C-C, Shadrin AA, Smeland OB, et al. The genetic architecture of human complex phenotypes is modulated by linkage disequilibrium and heterozygosity. Genetics. 2021;217:iyaa046.
pubmed: 33789345 pmcid: 8045737 doi: 10.1093/genetics/iyaa046
Zhang Q, Sidorenko J, Couvy-Duchesne B, Marioni RE, Wright MJ, Goate AM, et al. Risk prediction of late-onset Alzheimer’s disease implies an oligogenic architecture. Nat Commun. 2020;11:4799.
pubmed: 32968074 pmcid: 7511365 doi: 10.1038/s41467-020-18534-1
Bellenguez C, Küçükali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nat Genet. 2022;54:412–36.
pubmed: 35379992 pmcid: 9005347 doi: 10.1038/s41588-022-01024-z
Hou K, Bhattacharya A, Mester R, Burch KS, Pasaniuc B. On powerful GWAS in admixed populations. Nat Genet. 2021;53:1631–3.
pubmed: 34824480 pmcid: 8939372 doi: 10.1038/s41588-021-00953-5
Kunkle BW, Schmidt M, Klein H-U, Naj AC, Hamilton-Nelson KL, Larson EB, et al. Novel Alzheimer disease risk loci and pathways in African American individuals using the African genome resources panel: a meta-analysis. JAMA Neurol. 2021;78:102–13.
pubmed: 33074286 doi: 10.1001/jamaneurol.2020.3536
Blue EE, Arvr H, Mukherjee S, Wijsman EM, Thornton TA. Local ancestry at APOE modifies Alzheimer’s disease risk in Caribbean Hispanics. Alzheimers Dement. 2019;15:1524–32.
pubmed: 31606368 pmcid: 6925639 doi: 10.1016/j.jalz.2019.07.016
Graham SE, Clarke SL, Wu K-HH, Kanoni S, Zajac GJM, Ramdas S, et al. The power of genetic diversity in genome-wide association studies of lipids. Nature. 2021;600:675–9.
pubmed: 34887591 pmcid: 8730582 doi: 10.1038/s41586-021-04064-3
Mahajan A, Spracklen CN, Zhang W, Ng MCY, Petty LE, Kitajima H, et al. Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. Nat Genet. 2022;54:560–72.
pubmed: 35551307 pmcid: 9179018 doi: 10.1038/s41588-022-01058-3
McCartney DL, Min JL, Richmond RC, Lu AT, Sobczyk MK, Davies G, et al. Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging. Genome Biol. 2021;22:194.
pubmed: 34187551 pmcid: 8243879 doi: 10.1186/s13059-021-02398-9
Laisk T, Soares ALG, Ferreira T, Painter JN, Censin JC, Laber S, et al. The genetic architecture of sporadic and multiple consecutive miscarriage. Nat Commun. 2020;11:5980.
pubmed: 33239672 pmcid: 7689465 doi: 10.1038/s41467-020-19742-5
Chen M-H, Raffield LM, Mousas A, Sakaue S, Huffman JE, Moscati A, et al. Trans-ethnic and ancestry-specific blood-cell genetics in 746,667 individuals from 5 global populations. Cell. 2020;182:1198.
pubmed: 32888493 pmcid: 7480402 doi: 10.1016/j.cell.2020.06.045
Shu X, Long J, Cai Q, Kweon S-S, Choi J-Y, Kubo M, et al. Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants. Nat Commun. 2020;11:1217.
pubmed: 32139696 pmcid: 7057957 doi: 10.1038/s41467-020-15046-w
Tin A, Marten J, Halperin Kuhns VL, Li Y, Wuttke M, Kirsten H, et al. Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels. Nat Genet. 2019;51:1459.
pubmed: 31578528 pmcid: 6858555 doi: 10.1038/s41588-019-0504-x
Teumer A, Li Y, Ghasemi S, Prins BP, Wuttke M, Hermle T, et al. Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria. Nat Commun. 2019;10:4130.
pubmed: 31511532 pmcid: 6739370 doi: 10.1038/s41467-019-11576-0
Wuttke M, Li Y, Li M, Sieber KB, Feitosa MF, Gorski M, et al. A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat Genet. 2019;51:957.
pubmed: 31152163 pmcid: 6698888 doi: 10.1038/s41588-019-0407-x
Morris AP, Le TH, Wu H, Akbarov A, van der Most PJ, Hemani G, et al. Trans-ethnic kidney function association study reveals putative causal genes and effects on kidney-specific disease aetiologies. Nat Commun. 2019;10:29.
pubmed: 30604766 pmcid: 6318312 doi: 10.1038/s41467-018-07867-7
Daya M, Rafaels N, Brunetti TM, Chavan S, Levin AM, Shetty A, et al. Association study in African-admixed populations across the Americas recapitulates asthma risk loci in non-African populations. Nat Commun. 2019;10:880.
pubmed: 30787307 pmcid: 6382865 doi: 10.1038/s41467-019-08469-7
Shigemizu D, Mitsumori R, Akiyama S, Miyashita A, Morizono T, Higaki S, et al. Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer’s disease risk. Transl Psychiatry. 2021;11:151.
pubmed: 33654092 pmcid: 7925686 doi: 10.1038/s41398-021-01272-3
Kang S, Gim J, Lee J, Gunasekaran TI, Choi KY, Lee JJ, et al. Potential novel genes for late-onset Alzheimer’s disease in East-Asian descent identified by APOE-stratified genome-wide association study. J Alzheimers Dis. 2021;82:1451–60.
pubmed: 34151794 pmcid: 8461686 doi: 10.3233/JAD-210145
Conti DV, Darst BF, Moss LC, Saunders EJ, Sheng X, Chou A, et al. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nat Genet. 2021;53:65–75.
pubmed: 33398198 pmcid: 8148035 doi: 10.1038/s41588-020-00748-0
Ntalla I, Weng L-C, Cartwright JH, Hall AW, Sveinbjornsson G, Tucker NR, et al. Multi-ancestry GWAS of the electrocardiographic PR interval identifies 202 loci underlying cardiac conduction. Nat Commun. 2020;11:2542.
pubmed: 32439900 pmcid: 7242331 doi: 10.1038/s41467-020-15706-x
Bentley AR, Sung YJ, Brown MR, Winkler TW, Kraja AT, Ntalla I, et al. Multi-ancestry genome-wide gene-smoking interaction study of 387,272 individuals identifies new loci associated with serum lipids. Nat Genet. 2019;51:636–48.
pubmed: 30926973 pmcid: 6467258 doi: 10.1038/s41588-019-0378-y
Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7.
pubmed: 25722852 pmcid: 4342193 doi: 10.1186/s13742-015-0047-8
Mägi R, Horikoshi M, Sofer T, Mahajan A, Kitajima H, Franceschini N, et al. Trans-ethnic meta-regression of genome-wide association studies accounting for ancestry increases power for discovery and improves fine-mapping resolution. Hum Mol Genet. 2017;26:3639–50.
pubmed: 28911207 pmcid: 5755684 doi: 10.1093/hmg/ddx280
Ochoa D, Hercules A, Carmona M, Suveges D, Gonzalez-Uriarte A, Malangone C, et al. Open Targets Platform: supporting systematic drug-target identification and prioritisation. Nucleic Acids Res. 2021;49:D1302–D1310.
pubmed: 33196847 doi: 10.1093/nar/gkaa1027
Zeng B, Bendl J, Kosoy R, Fullard JF, Hoffman GE, Roussos P. Multi-ancestry eQTL meta-analysis of human brain identifies candidate causal variants for brain-related traits. Nat Genet. 2022;54:161–9.
pubmed: 35058635 pmcid: 8852232 doi: 10.1038/s41588-021-00987-9
Steele NZR, Carr JS, Bonham LW, Geier EG, Damotte V, Miller ZA, et al. Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: a case–control study. PLoS Med. 2017;14:e1002272.
pubmed: 28350795 pmcid: 5369701 doi: 10.1371/journal.pmed.1002272
Hirata J, Hosomichi K, Sakaue S, Kanai M, Nakaoka H, Ishigaki K, et al. Genetic and phenotypic landscape of the major histocompatibilty complex region in the Japanese population. Nat Genet. 2019;51:470–480.
pubmed: 30692682 doi: 10.1038/s41588-018-0336-0
Sánchez-Juan P, Moreno S, de Rojas I, Hernández I, Valero S, Alegret M, et al. The MAPT H1 haplotype is a risk factor for Alzheimer’s disease in APOE ε4 non-carriers. Front Aging Neurosci. 2019;11:327.
pubmed: 31866851 pmcid: 6905227 doi: 10.3389/fnagi.2019.00327
Wightman DP, Jansen IE, Savage JE, Shadrin AA, Bahrami S, Holland D, et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease. Nat Genet. 2021;53:1276–82.
pubmed: 34493870 pmcid: 10243600 doi: 10.1038/s41588-021-00921-z
Schwartzentruber J, Cooper S, Liu JZ, Barrio-Hernandez I, Bello E, Kumasaka N, et al. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer’s disease risk genes. Nat Genet. 2021;53:392–402.
pubmed: 33589840 pmcid: 7610386 doi: 10.1038/s41588-020-00776-w
Sirkis DW, Geier EG, Bonham LW, Karch CM, Yokoyama JS. Recent advances in the genetics of frontotemporal dementia. Curr Genet Med Rep. 2019;7:41–52.
pubmed: 31687268 pmcid: 6827567 doi: 10.1007/s40142-019-0160-6
Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson’s disease: a meta-genome wide association study. Lancet Neurol. 2019;18:1091.
pubmed: 31701892 pmcid: 8422160 doi: 10.1016/S1474-4422(19)30320-5
Nalls MA, Blauwendraat C, Sargent L, Vitale D, Leonard H, Iwaki H, et al. Evidence for GRN connecting multiple neurodegenerative diseases. Brain Commun. 2021;3:fcab095.
pubmed: 34693284 pmcid: 8134835 doi: 10.1093/braincomms/fcab095
Miyashita A, Koike A, Jun G, Wang L-S, Takahashi S, Matsubara E, et al. SORL1 is genetically associated with late-onset Alzheimer’s disease in Japanese, Koreans and Caucasians. PLoS ONE. 2013;8:e58618.
pubmed: 23565137 pmcid: 3614978 doi: 10.1371/journal.pone.0058618
Rajabli F, Feliciano BE, Celis K, Hamilton-Nelson KL, Whitehead PL, Adams LD, et al. Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations. PLoS Genet. 2018;14:e1007791.
pubmed: 30517106 pmcid: 6281216 doi: 10.1371/journal.pgen.1007791
Tosto G, Fu H, Vardarajan BN, Lee JH, Cheng R, Reyes-Dumeyer D, et al. F-box/LRR-repeat protein 7 is genetically associated with Alzheimer’s disease. Ann Clin Transl Neurol. 2015;2:810.
pubmed: 26339675 pmcid: 4554442 doi: 10.1002/acn3.223
Chen DT, Jiang X, Akula N, Shugart YY, Wendland JR, Steele CJM, et al. Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder. Mol Psychiatry. 2011;18:195–205.
pubmed: 22182935 doi: 10.1038/mp.2011.157
Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res. 2002;12:996–1006.
pubmed: 12045153 pmcid: 186604 doi: 10.1101/gr.229102
Schizophrenia Working Group of the Psychiatric Genomics Consortium, Ripke S, Neale BM, Corvin A, Walters JTR, Farh K-H, et al. Biological insights from 108 Schizophrenia-Associated Genetic Loci. Nature. 2014;511:421.
Lam M, Chen C-Y, Li Z, Martin AR, Bryois J, Ma X, et al. Comparative genetic architectures of schizophrenia in East Asian and European populations. Nat Genet. 2019;51:1670–8.
pubmed: 31740837 pmcid: 6885121 doi: 10.1038/s41588-019-0512-x
Ikeda M, Takahashi A, Kamatani Y, Momozawa Y, Saito T, Kondo K, et al. Genome-wide association study detected novel susceptibility genes for schizophrenia and shared trans-populations/diseases genetic effect. Schizophr Bull. 2019;45:824–34.
pubmed: 30285260 doi: 10.1093/schbul/sby140
Goes FS, Hamshere ML, Seifuddin F, Pirooznia M, Belmonte-Mahon P, Breuer R, et al. Genome-wide association of mood-incongruent psychotic bipolar disorder. Transl Psychiatry. 2012;2:e180.
pubmed: 23092984 pmcid: 3565814 doi: 10.1038/tp.2012.106
Ruderfer DM, Fanous AH, Ripke S, McQuillin A, Amdur RL. Schizophrenia Working Group of the Psychiatric Genomics Consortium, et al. Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Mol Psychiatry. 2014;19:1017–24.
pubmed: 24280982 doi: 10.1038/mp.2013.138
Mullins N, Forstner AJ, O’Connell KS, Coombes B, Coleman JRI, Qiao Z, et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 2021;53:817–29.
pubmed: 34002096 pmcid: 8192451 doi: 10.1038/s41588-021-00857-4
Drange OK, Smeland OB, Shadrin AA, Finseth PI, Witoelar A, Frei O, et al. Genetic overlap between Alzheimer’s disease and bipolar disorder implicates the MARK2 and VAC14 Genes. Front Neurosci. 2019;13:220.
pubmed: 30930738 pmcid: 6425305 doi: 10.3389/fnins.2019.00220
Li W, Cai X, Li H-J, Song M, Zhang C-Y, Yang Y, et al. Independent replications and integrative analyses confirm TRANK1 as a susceptibility gene for bipolar disorder. Neuropsychopharmacology. 2021;46:1103–12.
pubmed: 32791513 doi: 10.1038/s41386-020-00788-4
Jiang X, Detera-Wadleigh SD, Akula N, Mallon BS, Hou L, Xiao T, et al. Sodium valproate rescues expression of TRANK1 in iPSC-derived neural cells that carry a genetic variant associated with serious mental illness. Mol Psychiatry. 2019;24:613–24.
pubmed: 30135510 doi: 10.1038/s41380-018-0207-1
Gambuzza ME, Sofo V, Salmeri FM, Soraci L, Marino S, Bramanti P. Toll-like receptors in Alzheimer’s disease: a therapeutic perspective. CNS Neurol Disord Drug Targets. 2014;13:1542–58.
pubmed: 25106635 doi: 10.2174/1871527313666140806124850
Wolters FJ, Boender J, de Vries PS, Sonneveld MA, Koudstaal PJ, de Maat MP, et al. Von Willebrand factor and ADAMTS13 activity in relation to risk of dementia: a population-based study. Sci Rep. 2018;8:5474.
pubmed: 29615758 pmcid: 5882924 doi: 10.1038/s41598-018-23865-7
Li QS, De, Muynck L. Differentially expressed genes in Alzheimer’s disease highlighting the roles of microglia genes including OLR1 and astrocyte gene CDK2AP1. Brain Behav Immun Health. 2021;13:100227.
pubmed: 34589742 pmcid: 8474442 doi: 10.1016/j.bbih.2021.100227
Faux NG, Rembach A, Wiley J, Ellis KA, Ames D, Fowler CJ, et al. An anemia of Alzheimer’s disease. Mol Psychiatry. 2014;19:1227–34.
pubmed: 24419041 doi: 10.1038/mp.2013.178
Ramos-Cejudo J, Wisniewski T, Marmar C, Zetterberg H, Blennow K, de Leon MJ, et al. Traumatic Brain Injury and Alzheimer’s Disease: the cerebrovascular link. EBioMedicine. 2018;28:21–30.
pubmed: 29396300 pmcid: 5835563 doi: 10.1016/j.ebiom.2018.01.021
Dean M. The human ATP-binding cassette (ABC) transporter superfamily. USA: National Center for Biotechnology Information; 2002.
Cao QT, Aguiar JA, Tremblay BJ-M, Abbas N, Tiessen N, Revill S, et al. ABCF1 regulates dsDNA-induced immune responses in human airway epithelial cells. Front Cell Infect Microbiol. 2020;10:487.
pubmed: 33042865 pmcid: 7525020 doi: 10.3389/fcimb.2020.00487
Momtazmanesh S, Perry G, Rezaei N. Toll-like receptors in Alzheimer’s disease. J Neuroimmunol. 2020;348:577362.
pubmed: 32858428 doi: 10.1016/j.jneuroim.2020.577362
Courtney SC, Di H, Stockman BM, Liu H, Scherbik SV, Brinton MA. Identification of novel host cell binding partners of Oas1b, the protein conferring resistance to flavivirus-induced disease in mice. J Virol. 2012;86:7953–63.
pubmed: 22623793 pmcid: 3421638 doi: 10.1128/JVI.00333-12
Vittor AY, Long M, Chakrabarty P, Aycock L, Kollu V, DeKosky ST. West nile virus-induced neurologic sequelae-relationship to neurodegenerative cascades and dementias. Curr Trop Med Rep. 2020;7:25–36.
pubmed: 32775145 pmcid: 7409821 doi: 10.1007/s40475-020-00200-7
de Oliveira J, Kucharska E, Garcez ML, Rodrigues MS, Quevedo J, Moreno-Gonzalez I, et al. Inflammatory cascade in Alzheimer’s disease pathogenesis: a review of experimental findings. Cells. 2021;10:2581.
pubmed: 34685563 pmcid: 8533897 doi: 10.3390/cells10102581
Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet. 2006;38:209–13.
pubmed: 16415888 doi: 10.1038/ng1706
Vardarajan BN, Reyes-Dumeyer D, Piriz AL, Lantigua RA, Medrano M, Rivera D, et al. Progranulin mutations in clinical and neuropathological Alzheimer’s disease. Alzheimers Dement. 2022. https://doi.org/10.1002/alz.12567 .
Tönjes A, Scholz M, Krüger J, Krause K, Schleinitz D, Kirsten H, et al. Genome-wide meta-analysis identifies novel determinants of circulating serum progranulin. Hum Mol Genet. 2018;27:546–58.
pubmed: 29186428 doi: 10.1093/hmg/ddx413
Liu C, Yu J. Genome-wide association studies for cerebrospinal fluid soluble TREM2 in Alzheimer’s disease. Front Aging Neurosci. 2019;11:297.
pubmed: 31708768 pmcid: 6823606 doi: 10.3389/fnagi.2019.00297
Hou XH, Bi YL, Tan MS, Xu W, Li JQ, Shen XN, et al. Genome-wide association study identifies Alzheimer’s risk variant in MS4A6A influencing cerebrospinal fluid sTREM2 levels. Neurobiol Aging. 2019;84:241.e13–241.e20.
pubmed: 31204042 doi: 10.1016/j.neurobiolaging.2019.05.008
Deming Y, Filipello F, Cignarella F, Cantoni C, Hsu S, Mikesell R, et al. The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer’s disease risk. Sci Transl Med. 2019;11:eaau2291.
pubmed: 31413141 pmcid: 6697053 doi: 10.1126/scitranslmed.aau2291
Acosta-Uribe J, Aguillón D, Cochran JN, Giraldo M, Madrigal L, Killingsworth BW, et al. A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects. Genome Med. 2022;14:27.
pubmed: 35260199 pmcid: 8902761 doi: 10.1186/s13073-022-01035-9
Jiao B, Liu X, Tang B, Hou L, Zhou L, Zhang F, et al. Investigation of TREM2, PLD3, and UNC5C variants in patients with Alzheimer’s disease from mainland China. Neurobiol Aging. 2014;35:2422.e9–2422.e11.
pubmed: 24866402 doi: 10.1016/j.neurobiolaging.2014.04.025
Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BN, Wang L-S, et al. Variants in the ATP-binding cassette transporter (ABCA7), Apolipoprotein E ϵ4, and the risk of late-onset Alzheimer disease in African Americans. JAMA. 2013;309:1483–92.
pubmed: 23571587 pmcid: 3667653 doi: 10.1001/jama.2013.2973
Gianattasio KZ, Prather C, Glymour MM, Ciarleglio A, Power MC. Racial disparities and temporal trends in dementia misdiagnosis risk in the United States. Alzheimers Dement. 2019;5:891–8.
doi: 10.1016/j.trci.2019.11.008
Beach TG, Monsell SE, Phillips LE, Kukull W. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005–10. J Neuropathol Exp Neurol. 2012;71:266–73.
pubmed: 22437338 doi: 10.1097/NEN.0b013e31824b211b
Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat Genet. 2019;51:404–13.
pubmed: 30617256 pmcid: 6836675 doi: 10.1038/s41588-018-0311-9
Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, et al. A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline. Nature. 2012;488:96–99.
pubmed: 22801501 doi: 10.1038/nature11283
Sirkis DW, Bonham LW, Johnson TP, La Joie R, Yokoyama JS. Dissecting the clinical heterogeneity of early-onset Alzheimer’s disease. Mol Psychiatry. 2022;27:2674–88.
pubmed: 35393555 pmcid: 9156414 doi: 10.1038/s41380-022-01531-9
Deeks JJ, Higgins JPT, Altman DG, on behalf of the Cochrane Statistical Methods Group. Analysing data and undertaking meta‐analyses. Cochrane Handbook for Systematic Reviews of Interventions. 2019:241–84.
Gay NR, Gloudemans M, Antonio ML, Abell NS, Balliu B, Park Y, et al. Impact of admixture and ancestry on eQTL analysis and GWAS colocalization in GTEx. Genome Biol. 2020;21:233.
pubmed: 32912333 pmcid: 7488497 doi: 10.1186/s13059-020-02113-0
Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48:481–7.
pubmed: 27019110 doi: 10.1038/ng.3538
King EA, Wade Davis J, Degner JF. Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS Genet. 2019;15:e1008489.
pubmed: 31830040 pmcid: 6907751 doi: 10.1371/journal.pgen.1008489
Liu B, Gloudemans M, Rao AS, Ingelsson E, Montgomery SB. Abundant associations with gene expression complicate GWAS follow-up. Nat Genet. 2019;51:768.
pubmed: 31043754 pmcid: 6904208 doi: 10.1038/s41588-019-0404-0
Murphy AE, Schilder BM, Skene NG. MungeSumstats: a bioconductor package for the standardization and quality control of many GWAS summary statistics. Bioinformatics. 2021;37:4593–6.
pubmed: 34601555 pmcid: 8652100 doi: 10.1093/bioinformatics/btab665
Abraham G, Inouye M. Fast principal component analysis of large-scale genome-wide data. PLoS ONE. 2014;9:e93766.
pubmed: 24718290 pmcid: 3981753 doi: 10.1371/journal.pone.0093766
Montinaro F, Busby GBJ, Pascali VL, Myers S, Hellenthal G, Capelli C. Unravelling the hidden ancestry of American admixed populations. Nat Commun. 2015;6:1–7.
doi: 10.1038/ncomms7596
Tokunaga K, Ohashi J, Bannai M, Juji T. Genetic link between Asians and native Americans: evidence from HLA genes and haplotypes. Hum Immunol. 2001;62:1001–8.

Auteurs

Julie Lake (J)

Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.

Caroline Warly Solsberg (C)

Pharmaceutical Sciences and Pharmacogenomics, University of California, San Francisco, San Francisco, CA, USA.
Department of Neurology and Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.

Jonggeol Jeffrey Kim (JJ)

Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Preventive Neurology Unit, Centre for Prevention Diagnosis and Detection, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.

Juliana Acosta-Uribe (J)

Neuroscience Research Institute and the department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA, USA.
Neuroscience Group of Antioquia, University of Antioquia, Medellín, Colombia.

Mary B Makarious (MB)

Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.
UCL Movement Disorders Centre, University College London, London, UK.

Zizheng Li (Z)

Pharmaceutical Sciences and Pharmacogenomics, University of California, San Francisco, San Francisco, CA, USA.
Department of Neurology and Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.

Kristin Levine (K)

Data Tecnica International LLC, Washington, DC, USA.
Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, MD, USA.

Peter Heutink (P)

Alector, Inc. 131 Oyster Point Blvd, Suite 600, South San Francisco, CA, 94080, USA.

Chelsea X Alvarado (CX)

Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Data Tecnica International LLC, Washington, DC, USA.
Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, MD, USA.

Dan Vitale (D)

Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Data Tecnica International LLC, Washington, DC, USA.
Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, MD, USA.

Sarang Kang (S)

Gwangju Alzheimer's disease and Related Dementia Cohort Research Center, Chosun University, Gwangju, 61452, Korea.
BK FOUR Department of Integrative Biological Sciences, Chosun University, Gwangju, 61452, Korea.

Jungsoo Gim (J)

Gwangju Alzheimer's disease and Related Dementia Cohort Research Center, Chosun University, Gwangju, 61452, Korea.
BK FOUR Department of Integrative Biological Sciences, Chosun University, Gwangju, 61452, Korea.
Department of Biomedical Science, Chosun University, Gwangju, 61452, Korea.

Kun Ho Lee (KH)

Gwangju Alzheimer's disease and Related Dementia Cohort Research Center, Chosun University, Gwangju, 61452, Korea.
BK FOUR Department of Integrative Biological Sciences, Chosun University, Gwangju, 61452, Korea.
Department of Biomedical Science, Chosun University, Gwangju, 61452, Korea.
Korea Brain Research Institute, Daegu, 41062, Korea.

Stefanie D Pina-Escudero (SD)

Pharmaceutical Sciences and Pharmacogenomics, University of California, San Francisco, San Francisco, CA, USA.
Department of Neurology and Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.

Luigi Ferrucci (L)

Longitudinal Studies Section, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.

Andrew B Singleton (AB)

Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, MD, USA.

Cornelis Blauwendraat (C)

Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, MD, USA.
Integrative Neurogenomics Unit, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.

Mike A Nalls (MA)

Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Data Tecnica International LLC, Washington, DC, USA.
Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, MD, USA.

Jennifer S Yokoyama (JS)

Pharmaceutical Sciences and Pharmacogenomics, University of California, San Francisco, San Francisco, CA, USA.
Department of Neurology and Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, USA.

Hampton L Leonard (HL)

Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. leonardhl@nih.gov.
Data Tecnica International LLC, Washington, DC, USA. leonardhl@nih.gov.
Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, MD, USA. leonardhl@nih.gov.
German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. leonardhl@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH